- Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells.
Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells.
Oncology letters (2017-08-07)
María P Iturriaga, Rodolfo Paredes, Jose I Arias, Cristian G Torres
PMID28781660
ABSTRACT
Cyclooxygenase (COX)-2 expression is positively correlated with malignant features in canine mammary carcinomas. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX activity and may therefore possess anticancer effects. Meloxicam is an NSAID that is widely used in human and veterinary medicine. High concentrations of meloxicam have been reported to be antitumorigenic
MATERIALS
Product Number
Brand
Product Description
Sigma-Aldrich
Anti-Mouse IgG (Fab specific)–Peroxidase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Rabbit IgG (whole molecule), F(ab′)2 fragment−Peroxidase antibody produced in goat, affinity isolated antibody, buffered aqueous solution